-
1
-
-
79953783229
-
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases
-
21472708 10.1002/cncr.25746
-
Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA (2011) The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 117(8):1602-1611
-
(2011)
Cancer
, vol.117
, Issue.8
, pp. 1602-1611
-
-
Anders, C.K.1
Deal, A.M.2
Miller, C.R.3
Khorram, C.4
Meng, H.5
Burrows, E.6
Livasy, C.7
Fritchie, K.8
Ewend, M.G.9
Perou, C.M.10
Carey, L.A.11
-
2
-
-
36348947965
-
Trastuzumab prolongs overall survival in patients with brain metastases from HER2 positive breast cancer
-
17557136 10.1007/s11060-007-9420-5 1:CAS:528:DC%2BD2sXhsVygt77E
-
Bartsch R, Rottendusser A, Wenzel C et al (2007) Trastuzumab prolongs overall survival in patients with brain metastases from HER2 positive breast cancer. J Neurooncol 85:311-317
-
(2007)
J Neurooncol
, vol.85
, pp. 311-317
-
-
Bartsch, R.1
Rottendusser, A.2
Wenzel, C.3
-
3
-
-
38549134656
-
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: The dark side of the moon? A meta-analysis of the randomized trials
-
17638068 10.1007/s10549-007-9663-z 1:CAS:528:DC%2BD1cXlsV2nt74%3D
-
Bria E, Cuppone F, Fornier M, Nisticò C, Carlini P, Milella M, Sperduti I, Terzoli E, Cognetti F, Giannarelli D (2008) Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials. Breast Cancer Res Treat 109(2):231-239
-
(2008)
Breast Cancer Res Treat
, vol.109
, Issue.2
, pp. 231-239
-
-
Bria, E.1
Cuppone, F.2
Fornier, M.3
Nisticò, C.4
Carlini, P.5
Milella, M.6
Sperduti, I.7
Terzoli, E.8
Cognetti, F.9
Giannarelli, D.10
-
4
-
-
67650096888
-
Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: Discordance rates between primary and metastatic breast cancer
-
19443366
-
Broom RJ, Tang PA, Simmons C, Bordeleau L, Mulligan AM, O'Malley FP, Miller N, Andrulis IL, Brenner DM, Clemons MJ (2009) Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer. Anticancer Res 29(5):1557-1562
-
(2009)
Anticancer Res
, vol.29
, Issue.5
, pp. 1557-1562
-
-
Broom, R.J.1
Tang, P.A.2
Simmons, C.3
Bordeleau, L.4
Mulligan, A.M.5
O'Malley, F.P.6
Miller, N.7
Andrulis, I.L.8
Brenner, D.M.9
Clemons, M.J.10
-
5
-
-
44949181989
-
Extended survival in women receiving trastuzumab for brain metastases from HER2 positive metastatic breast cancer
-
18525303 10.1097/COC.0b013e31815a43c4 1:CAS:528:DC%2BD1cXntFWgu7k%3D
-
Church DN, Modgil R, Guglani S et al (2008) Extended survival in women receiving trastuzumab for brain metastases from HER2 positive metastatic breast cancer. Am J Clin Oncol 31:250-254
-
(2008)
Am J Clin Oncol
, vol.31
, pp. 250-254
-
-
Church, D.N.1
Modgil, R.2
Guglani, S.3
-
6
-
-
78650880204
-
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer
-
Epub 2010 Jul 6
-
Da Silva L, Simpson PT, Smart CE, Cocciardi S, Waddell N, Lane A, Morrison BJ, Vargas AC, Healey S, Beesley J, Pakkiri P, Parry S, Kurniawan N, Reid L, Keith P, Faria P, Pereira E, Skalova A, Bilous M, Balleine RL, Do H, Dobrovic A, Fox S, Franco M, Reynolds B, Khanna KK, Cummings M, Chenevix-Trench G, Lakhani SR. HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer. Breast Cancer Res. 2010;12(4):R46 (Epub 2010 Jul 6)
-
(2010)
Breast Cancer Res
, vol.12
, Issue.4
-
-
Da Silva, L.1
Simpson, P.T.2
Smart, C.E.3
Cocciardi, S.4
Waddell, N.5
Lane, A.6
Morrison, B.J.7
Vargas, A.C.8
Healey, S.9
Beesley, J.10
Pakkiri, P.11
Parry, S.12
Kurniawan, N.13
Reid, L.14
Keith, P.15
Faria, P.16
Pereira, E.17
Skalova, A.18
Bilous, M.19
Balleine, R.L.20
Do, H.21
Dobrovic, A.22
Fox, S.23
Franco, M.24
Reynolds, B.25
Khanna, K.K.26
Cummings, M.27
Chenevix-Trench, G.28
Lakhani, S.R.29
more..
-
7
-
-
46249099391
-
Defining prognosis for women with breast cancer and CNS metastases by HER2 status
-
18334512 10.1093/annonc/mdn036 1:STN:280:DC%2BD1cvgvVOkuw%3D%3D
-
Dawood S, Broglio K, Esteva FJ, Ibrahim NK, Kau SW, Islam R, Aldape KD, Yu TK, Hortobagyi GN, Gonzalez-Angulo AM (2008) Defining prognosis for women with breast cancer and CNS metastases by HER2 status. Ann Oncol 19(7):1242-1248
-
(2008)
Ann Oncol
, vol.19
, Issue.7
, pp. 1242-1248
-
-
Dawood, S.1
Broglio, K.2
Esteva, F.J.3
Ibrahim, N.K.4
Kau, S.W.5
Islam, R.6
Aldape, K.D.7
Yu, T.K.8
Hortobagyi, G.N.9
Gonzalez-Angulo, A.M.10
-
8
-
-
63549116437
-
Survival among women with triple receptor-negative breast cancer and brain metastases
-
19150943 10.1093/annonc/mdn682 1:STN:280:DC%2BD1M3jt1eqtA%3D%3D
-
Dawood S, Broglio K, Esteva FJ, Yang W, Kau SW, Islam R, Albarracin C, Yu TK, Green M, Hortobagyi GN, Gonzalez-Angulo AM (2009) Survival among women with triple receptor-negative breast cancer and brain metastases. Ann Oncol 20(4):621-627
-
(2009)
Ann Oncol
, vol.20
, Issue.4
, pp. 621-627
-
-
Dawood, S.1
Broglio, K.2
Esteva, F.J.3
Yang, W.4
Kau, S.W.5
Islam, R.6
Albarracin, C.7
Yu, T.K.8
Green, M.9
Hortobagyi, G.N.10
Gonzalez-Angulo, A.M.11
-
9
-
-
73949090721
-
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
-
19933921 10.1200/JCO.2008.19.9844 1:CAS:528:DC%2BC3cXhtF2rsr0%3D
-
Dawood S, Broglio K, Buzdar AU, Hortobagyi GN, Giordano SH (2010) Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28(1):92-98
-
(2010)
J Clin Oncol
, vol.28
, Issue.1
, pp. 92-98
-
-
Dawood, S.1
Broglio, K.2
Buzdar, A.U.3
Hortobagyi, G.N.4
Giordano, S.H.5
-
10
-
-
0042817853
-
ErbB-2 (HER-2) and breast cancer progression
-
12966347 10.1097/00129039-200309000-00003 1:CAS:528:DC%2BD3sXntFSnsbY%3D
-
Edgerton SM, Moore D 2nd, Merkel D, Thor AD (2003) erbB-2 (HER-2) and breast cancer progression. Appl Immunohistochem Mol Morphol 11(3):214-221
-
(2003)
Appl Immunohistochem Mol Morphol
, vol.11
, Issue.3
, pp. 214-221
-
-
Edgerton, S.M.1
Moore II, D.2
Merkel, D.3
Thor, A.D.4
-
11
-
-
0036788636
-
HER2 in brain metastases: Issues of concordance, survival, and treatment
-
12351617 10.1200/JCO.2002.04.016
-
Fuchs IB, Loebbecke M, Buhler H, Stoltenburg-Didinger G, Heine B, Lichtenegger W, Schaller G (2002) HER2 in brain metastases: issues of concordance, survival, and treatment. J Clin Oncol 20(19):4130-4133
-
(2002)
J Clin Oncol
, vol.20
, Issue.19
, pp. 4130-4133
-
-
Fuchs, I.B.1
Loebbecke, M.2
Buhler, H.3
Stoltenburg-Didinger, G.4
Heine, B.5
Lichtenegger, W.6
Schaller, G.7
-
12
-
-
34247346051
-
Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer
-
17102066 10.1200/JCO.2006.07.0250 1:CAS:528:DC%2BD2sXhtVChsrc%3D
-
Gabos Z, Sinha R, Hanson J, Chauhan N, Hugh J, Mackey JR, Abdulkarim B (2006) Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 24(36):5658-5663
-
(2006)
J Clin Oncol
, vol.24
, Issue.36
, pp. 5658-5663
-
-
Gabos, Z.1
Sinha, R.2
Hanson, J.3
Chauhan, N.4
Hugh, J.5
Mackey, J.R.6
Abdulkarim, B.7
-
13
-
-
34447581059
-
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
-
Epub 1 Jun 2007
-
Gaedcke J, Traub F, Milde S, Wilkens L, Stan A, Ostertag H, Christgen M, von Wasielewski R, Kreipe HH (2007) Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod Pathol 20(8):864-70 (Epub 1 Jun 2007)
-
(2007)
Mod Pathol
, vol.20
, Issue.8
, pp. 864-870
-
-
Gaedcke, J.1
Traub, F.2
Milde, S.3
Wilkens, L.4
Stan, A.5
Ostertag, H.6
Christgen, M.7
Von Wasielewski, R.8
Kreipe, H.H.9
-
14
-
-
77949391758
-
Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance
-
20154280 10.1309/AJCPJ57FLLJRXKPV
-
Idirisinghe PK, Thike AA, Cheok PY, Tse GM, Lui PC, Fook-Chong S, Wong NS, Tan PH (2010) Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance. Am J Clin Pathol 133(3):416-429
-
(2010)
Am J Clin Pathol
, vol.133
, Issue.3
, pp. 416-429
-
-
Idirisinghe, P.K.1
Thike, A.A.2
Cheok, P.Y.3
Tse, G.M.4
Lui, P.C.5
Fook-Chong, S.6
Wong, N.S.7
Tan, P.H.8
-
15
-
-
0026059293
-
Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer
-
1682277 10.1002/ijc.2910490504 1:STN:280:DyaK38%2FktVelsQ%3D%3D
-
Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ (1991) Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 49(5):650-655
-
(1991)
Int J Cancer
, vol.49
, Issue.5
, pp. 650-655
-
-
Kallioniemi, O.P.1
Holli, K.2
Visakorpi, T.3
Koivula, T.4
Helin, H.H.5
Isola, J.J.6
-
16
-
-
77950074588
-
The upgraded role of HER3 and HER4 receptors in breast cancer
-
19481955 10.1016/j.critrevonc.2009.04.011
-
Koutras AK, Fountzilas G, Kalogeras KT, Starakis I, Iconomou G, Kalofonos HP (2010) The upgraded role of HER3 and HER4 receptors in breast cancer. Crit Rev Oncol Hematol 74(2):73-78
-
(2010)
Crit Rev Oncol Hematol
, vol.74
, Issue.2
, pp. 73-78
-
-
Koutras, A.K.1
Fountzilas, G.2
Kalogeras, K.T.3
Starakis, I.4
Iconomou, G.5
Kalofonos, H.P.6
-
17
-
-
0242335682
-
Her-2/neu status in breast cancer metastases to the central nervous system
-
14567724 1:CAS:528:DC%2BD3sXpsVCru70%3D
-
Lear-Kaul KC, Yoon HR, Kleinschmidt-DeMasters BK, McGavran L, Singh M (2003) Her-2/neu status in breast cancer metastases to the central nervous system. Arch Pathol Lab Med 127(11):1451-1457
-
(2003)
Arch Pathol Lab Med
, vol.127
, Issue.11
, pp. 1451-1457
-
-
Lear-Kaul, K.C.1
Yoon, H.R.2
Kleinschmidt-Demasters, B.K.3
McGavran, L.4
Singh, M.5
-
18
-
-
70449698237
-
Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases
-
19770385 10.1200/JCO.2008.19.8481
-
Leyland-Jones B (2009) Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases. J Clin Oncol 27(31):5278-5286
-
(2009)
J Clin Oncol
, vol.27
, Issue.31
, pp. 5278-5286
-
-
Leyland-Jones, B.1
-
19
-
-
0041696795
-
Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival
-
12864939 10.3816/CBC.2003.n.016 1:CAS:528:DC%2BD3sXmt1Olsrk%3D
-
Lower EE, Drosick DR, Blau R et al (2003) Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival. Clin Breast Cancer 4:114-119
-
(2003)
Clin Breast Cancer
, vol.4
, pp. 114-119
-
-
Lower, E.E.1
Drosick, D.R.2
Blau, R.3
-
20
-
-
22344446208
-
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: The M77001 study group
-
15911866 10.1200/JCO.2005.04.173 1:CAS:528:DC%2BD2MXms12gs70%3D
-
Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M, Chan S, Grimes D, Antón A, Lluch A, Kennedy J, O'Byrne K, Conte P, Green M, Ward C, Mayne K, Extra JM (2005) Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol 23(19):4265-4274
-
(2005)
J Clin Oncol
, vol.23
, Issue.19
, pp. 4265-4274
-
-
Marty, M.1
Cognetti, F.2
Maraninchi, D.3
Snyder, R.4
Mauriac, L.5
Tubiana-Hulin, M.6
Chan, S.7
Grimes, D.8
Antón, A.9
Lluch, A.10
Kennedy, J.11
O'Byrne, K.12
Conte, P.13
Green, M.14
Ward, C.15
Mayne, K.16
Extra, J.M.17
-
21
-
-
79955455179
-
Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: Epidemiological and clinical data from a population-based cancer registry study
-
21509760 10.1002/cncr.25771
-
Musolino A, Ciccolallo L, Panebianco M, Fontana E, Zanoni D, Bozzetti C, Michiara M, Silini EM, Ardizzoni A (2011) Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study. Cancer 117(9):1837-1846
-
(2011)
Cancer
, vol.117
, Issue.9
, pp. 1837-1846
-
-
Musolino, A.1
Ciccolallo, L.2
Panebianco, M.3
Fontana, E.4
Zanoni, D.5
Bozzetti, C.6
Michiara, M.7
Silini, E.M.8
Ardizzoni, A.9
-
22
-
-
58949099515
-
Trastuzumab treatment beyond progression in HER2-positive metastatic breast cancer
-
18664558 10.1093/annonc/mdn539 1:STN:280:DC%2BD1M%2Fns1yltA%3D%3D
-
Park IH, Ro J, Lee KS et al (2009) Trastuzumab treatment beyond progression in HER2-positive metastatic breast cancer. Ann Oncol 20:56-62
-
(2009)
Ann Oncol
, vol.20
, pp. 56-62
-
-
Park, I.H.1
Ro, J.2
Lee, K.S.3
-
23
-
-
33646869874
-
International Breast Cancer Study Group (IBCSG). Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
-
16603601 10.1093/annonc/mdl064 1:STN:280:DC%2BD283nslenuw%3D%3D
-
Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E, Pagani O, Simoncini E, Castiglione-Gertsch M, Gelber RD, Coates AS (2006) International Breast Cancer Study Group (IBCSG). Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 17(6):935-944
-
(2006)
Ann Oncol
, vol.17
, Issue.6
, pp. 935-944
-
-
Pestalozzi, B.C.1
Zahrieh, D.2
Price, K.N.3
Holmberg, S.B.4
Lindtner, J.5
Collins, J.6
Crivellari, D.7
Fey, M.F.8
Murray, E.9
Pagani, O.10
Simoncini, E.11
Castiglione-Gertsch, M.12
Gelber, R.D.13
Coates, A.S.14
-
24
-
-
78649959817
-
Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis
-
21041379 10.1634/theoncologist.2010-0059
-
Pusztai L, Viale G, Kelly CM, Hudis CA (2010) Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis. Oncologist 15(11):1164-1168
-
(2010)
Oncologist
, vol.15
, Issue.11
, pp. 1164-1168
-
-
Pusztai, L.1
Viale, G.2
Kelly, C.M.3
Hudis, C.A.4
-
25
-
-
26844536978
-
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
-
16236738 10.1056/NEJMoa052122 1:CAS:528:DC%2BD2MXhtFansr3F
-
Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353(16):1673-1684
-
(2005)
N Engl J Med
, vol.353
, Issue.16
, pp. 1673-1684
-
-
Romond, E.H.1
Perez, E.A.2
Bryant, J.3
Suman, V.J.4
Geyer, Jr.C.E.5
Davidson, N.E.6
Tan-Chiu, E.7
Martino, S.8
Paik, S.9
Kaufman, P.A.10
Swain, S.M.11
Pisansky, T.M.12
Fehrenbacher, L.13
Kutteh, L.A.14
Vogel, V.G.15
Visscher, D.W.16
Yothers, G.17
Jenkins, R.B.18
Brown, A.M.19
Dakhil, S.R.20
Mamounas, E.P.21
Lingle, W.L.22
Klein, P.M.23
Ingle, J.N.24
Wolmark, N.25
more..
-
26
-
-
84878662129
-
Molecular aspects of breast cancer metastasis to the brain
-
Epub Nov 29 2011. UQ Centre for Clinical Research, The University of Queensland, Herston
-
Saunus JM, Momeny M, Simpson PT, Lakhani SR, Da Silva L (2011) Molecular aspects of breast cancer metastasis to the brain. Genet Res Int, 219189 (Epub Nov 29 2011). UQ Centre for Clinical Research, The University of Queensland, Herston
-
(2011)
Genet Res Int
, pp. 219189
-
-
Saunus, J.M.1
Momeny, M.2
Simpson, P.T.3
Lakhani, S.R.4
Da Silva, L.5
-
27
-
-
69849090104
-
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
-
19299408 10.1093/annonc/mdp028 1:STN:280:DC%2BD1MrnsVaqtg%3D%3D
-
Simmons C, Miller N, Geddie W, Gianfelice D, Oldfield M, Dranitsaris G, Clemons MJ (2009) Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? Ann Oncol 20(9):1499-1504
-
(2009)
Ann Oncol
, vol.20
, Issue.9
, pp. 1499-1504
-
-
Simmons, C.1
Miller, N.2
Geddie, W.3
Gianfelice, D.4
Oldfield, M.5
Dranitsaris, G.6
Clemons, M.J.7
-
28
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
-
11248153 10.1056/NEJM200103153441101 1:CAS:528:DC%2BD3MXisVGktrc%3D
-
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344(11):783-792
-
(2001)
N Engl J Med
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
Fuchs, H.4
Paton, V.5
Bajamonde, A.6
Fleming, T.7
Eiermann, W.8
Wolter, J.9
Pegram, M.10
Baselga, J.11
Norton, L.12
-
29
-
-
9444242163
-
Risk factors for brain relapse in patients with metastatic breast cancer
-
15520065 10.1093/annonc/mdh432 1:STN:280:DC%2BD2crkslSksw%3D%3D
-
Slimane K, Andre F, Delaloge S, Dunant A, Perez A, Grenier J, Massard C, Spielmann M (2004) Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol 15(11):1640-1644
-
(2004)
Ann Oncol
, vol.15
, Issue.11
, pp. 1640-1644
-
-
Slimane, K.1
Andre, F.2
Delaloge, S.3
Dunant, A.4
Perez, A.5
Grenier, J.6
Massard, C.7
Spielmann, M.8
-
30
-
-
33845914783
-
HERA study team. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: A randomised controlled trial
-
17208639 10.1016/S0140-6736(07)60028-2 1:CAS:528:DC%2BD2sXit12itg%3D%3D
-
Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, Kaufmann M, Cameron D, Bell R, Bergh J, Coleman R, Wardley A, Harbeck N, Lopez RI, Mallmann P, Gelmon K, Wilcken N, Wist E, Sánchez Rovira P, Piccart-Gebhart MJ (2007) HERA study team. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369(9555):29-36
-
(2007)
Lancet
, vol.369
, Issue.9555
, pp. 29-36
-
-
Smith, I.1
Procter, M.2
Gelber, R.D.3
Guillaume, S.4
Feyereislova, A.5
Dowsett, M.6
Goldhirsch, A.7
Untch, M.8
Mariani, G.9
Baselga, J.10
Kaufmann, M.11
Cameron, D.12
Bell, R.13
Bergh, J.14
Coleman, R.15
Wardley, A.16
Harbeck, N.17
Lopez, R.I.18
Mallmann, P.19
Gelmon, K.20
Wilcken, N.21
Wist, E.22
Sánchez Rovira, P.23
Piccart-Gebhart, M.J.24
more..
-
31
-
-
0345098483
-
Do we need HER-2/neu testing for all patients with primary breast carcinoma?
-
14669272 10.1002/cncr.11828 1:CAS:528:DC%2BD2cXit1yhsA%3D%3D
-
Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R (2003) Do we need HER-2/neu testing for all patients with primary breast carcinoma? Cancer 98(12):2547-2553
-
(2003)
Cancer
, vol.98
, Issue.12
, pp. 2547-2553
-
-
Taucher, S.1
Rudas, M.2
Mader, R.M.3
Gnant, M.4
Dubsky, P.5
Bachleitner, T.6
Roka, S.7
Fitzal, F.8
Kandioler, D.9
Sporn, E.10
Friedl, J.11
Mittlböck, M.12
Jakesz, R.13
-
32
-
-
0021050124
-
Central nervous system metastasis from breast carcinoma. Autopsy study
-
6640506 10.1002/1097-0142(19831215)52:12<2349: AID- CNCR2820521231>3.0.CO;2-B 1:STN:280:DyaL2c%2FlsV2qtg%3D%3D
-
Tsukada Y, Fouad A, Pickren JW, Lane WW (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52(12):2349-2354
-
(1983)
Cancer
, vol.52
, Issue.12
, pp. 2349-2354
-
-
Tsukada, Y.1
Fouad, A.2
Pickren, J.W.3
Lane, W.W.4
-
33
-
-
53349171202
-
Immunohistochemical profiles of brain metastases from breast cancer
-
18648908 10.1007/s11060-008-9654-x
-
Yonemori K, Tsuta K, Shimizu C, Hatanaka Y, Hashizume K, Ono M, Nakanishi Y, Hasegawa T, Miyakita Y, Narita Y, Shibui S, Fujiwara Y (2008) Immunohistochemical profiles of brain metastases from breast cancer. J Neurooncol 90(2):223-228
-
(2008)
J Neurooncol
, vol.90
, Issue.2
, pp. 223-228
-
-
Yonemori, K.1
Tsuta, K.2
Shimizu, C.3
Hatanaka, Y.4
Hashizume, K.5
Ono, M.6
Nakanishi, Y.7
Hasegawa, T.8
Miyakita, Y.9
Narita, Y.10
Shibui, S.11
Fujiwara, Y.12
|